Portal:ExRNA/FeaturedPathways
From WikiPathways
(Difference between revisions)
(adding new pathways) |
|||
Line 21: | Line 21: | ||
|width=100px|{{#pwimage:Pathway:WP2928|250px||miR-222 in Exercise-Induced Cardiac Growth}} | |width=100px|{{#pwimage:Pathway:WP2928|250px||miR-222 in Exercise-Induced Cardiac Growth}} | ||
[http://dx.doi.org/10.1016/j.cmet.2015.02.014 Liu, et al. miR-222 Is Necessary for Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling] | [http://dx.doi.org/10.1016/j.cmet.2015.02.014 Liu, et al. miR-222 Is Necessary for Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling] | ||
+ | |width=100px|{{#pwimage:Pathway:WP2943|250px||Hypoxia-mediated EMT and Stemness}} | ||
+ | [http://dx.doi.org/10.1038/ncomms6203, van den Beucken, et al. Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER] | ||
+ | |width=100px|{{#pwimage:Pathway:WP2942|250px||DDX1 as a regulatory component of the Drosha microprocessor}} | ||
+ | [http://dx.doi.org/10.1016/j.celrep.2014.07.058, Han, et al. The RNA-binding protein DDX1 promotes primary microRNA maturation and inhibits ovarian tumor progression] | ||
+ | |width=100px|{{#pwimage:Pathway:WP2261|250px||Signaling Pathways in Glioblastoma}} | ||
+ | |- | ||
|width=100px|{{#pwimage:Pathway:WP2012|250px||miRs in Muscle Cell Differentiation}} | |width=100px|{{#pwimage:Pathway:WP2012|250px||miRs in Muscle Cell Differentiation}} | ||
|width=100px|{{#pwImage:Pathway:WP2011|250px||REBF and miR33 in cholesterol and lipid homeostasis}} | |width=100px|{{#pwImage:Pathway:WP2011|250px||REBF and miR33 in cholesterol and lipid homeostasis}} | ||
|width=100px|{{#pwImage:Pathway:WP1991|250px||SRF and miRs in Smooth Muscle Differentiation and Proliferation}} | |width=100px|{{#pwImage:Pathway:WP1991|250px||SRF and miRs in Smooth Muscle Differentiation and Proliferation}} | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
|width=100px|{{#pwimage:Pathway:WP2910|250px||Mecp2 and Associated Rett Syndrome}} | |width=100px|{{#pwimage:Pathway:WP2910|250px||Mecp2 and Associated Rett Syndrome}} | ||
|- | |- | ||
Line 62: | Line 52: | ||
|width=100px|{{#pwimage:Pathway:WP1901|250px||Regulatory RNA pathways}} | |width=100px|{{#pwimage:Pathway:WP1901|250px||Regulatory RNA pathways}} | ||
|- | |- | ||
- | |||
|width=100px|{{#pwImage:Pathway:WP1530|250px||miRNA Regulation of DNA Damage Response}} | |width=100px|{{#pwImage:Pathway:WP1530|250px||miRNA Regulation of DNA Damage Response}} | ||
+ | |width=100px|{{#pwImage:Pathway:WP2002|250px||miR-targeted genes in epithelium - TarBase}} | ||
+ | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | ||
+ | |width=100px|{{#pwImage:Pathway:WP2003|250px||miR-targeted genes in leukocytes - TarBase}} | ||
+ | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | ||
+ | |width=100px|{{#pwImage:Pathway:WP2006|250px||miR-targeted genes in squamous cell - TarBase}} | ||
+ | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | ||
+ | |- | ||
+ | |width=100px|{{#pwImage:Pathway:WP1992|250px||TarBasePathway}} | ||
+ | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | ||
+ | |width=100px|{{#pwImage:Pathway:WP2005|250px||miR-targeted genes in muscle cell - TarBase}} | ||
+ | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | ||
+ | |width=100px|{{#pwImage:Pathway:WP2004|250px||miR-targeted genes in lymphocytes - TarBase}} | ||
+ | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | ||
+ | |width=100px|{{#pwImage:Pathway:WP2001|250px||miR-targeted genes in adipocytes - TarBase}} | ||
+ | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | ||
|} | |} |
Revision as of 22:47, 5 June 2015
Image does not exist |
Image does not exist |
Image does not exist Ozpolat, et al. Liposomal siRNA nanocarriers for cancer therapy Thomas, et al. Eri1: a conserved enzyme at the crossroads of multiple RNA-processing pathways |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |